• Overview
    Overview
  • Revenue
    Revenue
  • Segments
    • Revenue by Product
    • Revenue by Region
    Segments
  • Financials
    • Income Statement
    • Balance Sheet
    • Cashflow Statements
    • Profitability
    • Ratios
    Financials
  • People
    • CEO Salary
    • Employees
    • Revenue per Employee
    • Net Income per Employee
    People
  • OwnershipOwnership
    Ownership
  • Competitors
    Competitors
  • Stocks
    • Market Cap
    • PE Ratio
    • Stock Split
    • Dividend
    Stocks
  • News
    • Company News
    • Press Releases
    News
  • Earnings Calls
    Earnings Calls
  • Documents
    • Annual Reports
    • Quarterly Reports
    • SEC Filings
    Documents
Submit Feedback
Submit Feedback (Sign in required)
Bullfincher logo
Recent searches
    Trending searches
    • Company logo Caterpillar Overview
    • Company logo Apple Revenue
    • Company logo NVIDIA Corporation Employees
    • Company logo Microsoft Corporati... Revenue by segment
    • Company logo Amazon.com Financials
    • Company logo Tesla Overview
    • Home
    • Companies
    • Calendars
    • Ranking
    • Blog
    • Login

    Submit feedback to Bullfincher

    JNJ logo Johnson & Johnson +
    JNJ logo
    Johnson & Johnson
    +
    • Overview
    • Revenue
    • Segments
      • Revenue by Product
      • Revenue by Region
    • Financials
      • Income Statement
      • Balance Sheet
      • Cashflow Statement
      • Profitability
      • Ratios
    • People
      • CEO Salary
      • Employees
      • Revenue per Employee
      • Net Income per Employee
    • Ownership
    • Competitors
    • Stocks
      • Market Cap
      • PE Ratio
      • Stock Split
      • Dividend
    • News
      • Company News
      • Press Releases
    • Earnings Calls
    • Documents
      • Annual Report 10K
      • Quarterly Report 10Q
      • SEC Filings
    JNJ logo Johnson & Johnson JNJ + Follow
    • Revenue
    • Employees
    • Market Capitalization

    Johnson & Johnson's Revenue (2016 - 2025)

    • Johnson & Johnson's annual revenue was $94.19 B in fiscal year 2025. The annual revenue increased $5.37 B from $88.82 B (in 2024) to $94.19 B (in 2025), representing a 6.05% year-over-year growth.

    • Johnson & Johnson's quarterly revenue was $24.06 B in the quarter ending Mar 2026. The quarterly revenue increased $2.17 B from $21.89 B (in Q1: Dec 2025) to $24.06 B (in Q1: Dec 2026), representing a 9.91% year-over-year growth.

    • Over the past 10 years (2016 - 2025):
    • The highest annual revenue for Johnson & Johnson was $94.19 B in fiscal year 2025.
    • The lowest annual revenue was $71.89 B in fiscal year 2016.
    • The average revenue was $82.15 B.

    • Learn more about Johnson & Johnson's Revenue by Segment and Revenue by Region.

      Check out competitors to Johnson & Johnson in a side-by-side comparison.

      Explore additional financial metrics for Johnson & Johnson.


      Definition of Revenue :
    • Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
    Continue reading...

    Johnson & Johnson's Revenue Trend

    2015 70074000000.00
    2016 71890000000.00
    2017 76450000000.00
    2018 81581000000.00
    2019 82059000000.00
    2020 82584000000.00
    2021 78740000000.00
    2022 79990000000.00
    2023 85159000000.00
    2024 88821000000.00
    2025 94193000000.00
    Apr 2016 17482000000.00
    Jul 2016 18482000000.00
    Oct 2016 17820000000.00
    Dec 2016 18106000000.00
    Apr 2017 17766000000.00
    Jul 2017 18839000000.00
    Oct 2017 19650000000.00
    Dec 2017 20195000000.00
    Apr 2018 20009000000.00
    Jul 2018 20830000000.00
    Sep 2018 20348000000.00
    Dec 2018 20394000000.00
    Mar 2019 20021000000.00
    Jun 2019 20562000000.00
    Sep 2019 20729000000.00
    Dec 2019 20747000000.00
    Mar 2020 20691000000.00
    Jun 2020 18336000000.00
    Sep 2020 21082000000.00
    Dec 2020 22475000000.00
    Apr 2021 22321000000.00
    Jul 2021 23312000000.00
    Oct 2021 23338000000.00
    Dec 2021 24804000000.00
    Apr 2022 23426000000.00
    Jul 2022 24020000000.00
    Oct 2022 19996000000.00
    Dec 2022 23706000000.00
    Apr 2023 20894000000.00
    Jul 2023 21519000000.00
    Oct 2023 21351000000.00
    Dec 2023 21395000000.00
    Mar 2024 21383000000.00
    Jun 2024 22447000000.00
    Sep 2024 22471000000.00
    Dec 2024 22520000000.00
    Mar 2025 21893000000.00
    Jun 2025 23743000000.00
    Sep 2025 23993000000.00
    Dec 2025 24564000000.00
    Mar 2026 24062000000.00

    2025

    Johnson & Johnson's annual revenue was $94.19 B in fiscal year 2025.

    Johnson & Johnson's quarterly revenue was $21.89 B(Q1: Mar 2025), $23.74 B(Q2: Jun 2025), $23.99 B(Q3: Sep 2025), $24.56 B(Q4: Dec 2025) in fiscal year 2025.

    2024

    Johnson & Johnson's annual revenue was $88.82 B in fiscal year 2024.

    Johnson & Johnson's quarterly revenue was $21.38 B(Q1: Mar 2024), $22.45 B(Q2: Jun 2024), $22.47 B(Q3: Sep 2024), $22.52 B(Q4: Dec 2024) in fiscal year 2024.

    2023

    Johnson & Johnson's annual revenue was $85.16 B in fiscal year 2023.

    Johnson & Johnson's quarterly revenue was $20.89 B(Q1: Apr 2023), $21.52 B(Q2: Jul 2023), $21.35 B(Q3: Oct 2023), $21.40 B(Q4: Dec 2023) in fiscal year 2023.

    2022

    Johnson & Johnson's annual revenue was $79.99 B in fiscal year 2022.

    Johnson & Johnson's quarterly revenue was $23.43 B(Q1: Apr 2022), $24.02 B(Q2: Jul 2022), $20.00 B(Q3: Oct 2022), $23.71 B(Q4: Dec 2022) in fiscal year 2022.

    2021

    Johnson & Johnson's annual revenue was $78.74 B in fiscal year 2021.

    Johnson & Johnson's quarterly revenue was $22.32 B(Q1: Apr 2021), $23.31 B(Q2: Jul 2021), $23.34 B(Q3: Oct 2021), $24.80 B(Q4: Dec 2021) in fiscal year 2021.

    2020

    Johnson & Johnson's annual revenue was $82.58 B in fiscal year 2020.

    Johnson & Johnson's quarterly revenue was $20.69 B(Q1: Mar 2020), $18.34 B(Q2: Jun 2020), $21.08 B(Q3: Sep 2020), $22.48 B(Q4: Dec 2020) in fiscal year 2020.

    2019

    Johnson & Johnson's annual revenue was $82.06 B in fiscal year 2019.

    Johnson & Johnson's quarterly revenue was $20.02 B(Q1: Mar 2019), $20.56 B(Q2: Jun 2019), $20.73 B(Q3: Sep 2019), $20.75 B(Q4: Dec 2019) in fiscal year 2019.

    2018

    Johnson & Johnson's annual revenue was $81.58 B in fiscal year 2018.

    Johnson & Johnson's quarterly revenue was $20.01 B(Q1: Apr 2018), $20.83 B(Q2: Jul 2018), $20.35 B(Q3: Sep 2018), $20.39 B(Q4: Dec 2018) in fiscal year 2018.

    2017

    Johnson & Johnson's annual revenue was $76.45 B in fiscal year 2017.

    Johnson & Johnson's quarterly revenue was $17.77 B(Q1: Apr 2017), $18.84 B(Q2: Jul 2017), $19.65 B(Q3: Oct 2017), $20.20 B(Q4: Dec 2017) in fiscal year 2017.

    2016

    Johnson & Johnson's annual revenue was $71.89 B in fiscal year 2016.

    Johnson & Johnson's quarterly revenue was $17.48 B(Q1: Apr 2016), $18.48 B(Q2: Jul 2016), $17.82 B(Q3: Oct 2016), $18.11 B(Q4: Dec 2016) in fiscal year 2016.

    Continue reading...

    Johnson & Johnson's Revenue (Year-over-Year Change)

    2015 0
    2016 +2.59
    2017 +6.34
    2018 +6.71
    2019 +0.59
    2020 +0.64
    2021 -4.65
    2022 +1.59
    2023 +6.46
    2024 +4.30
    2025 +6.05
    Q1: Apr 16 0.62
    Q2: Jul 16 3.91
    Q3: Oct 16 4.20
    Q4: Dec 16 1.66
    Q1: Apr 17 1.62
    Q2: Jul 17 1.93
    Q3: Oct 17 10.27
    Q4: Dec 17 11.54
    Q1: Apr 18 12.63
    Q2: Jul 18 10.57
    Q3: Sep 18 3.55
    Q4: Dec 18 0.99
    Q1: Mar 19 0.06
    Q2: Jun 19 -1.29
    Q3: Sep 19 1.87
    Q4: Dec 19 1.73
    Q1: Mar 20 3.35
    Q2: Jun 20 -10.83
    Q3: Sep 20 1.70
    Q4: Dec 20 8.33
    Q1: Apr 21 7.88
    Q2: Jul 21 27.14
    Q3: Oct 21 10.70
    Q4: Dec 21 10.36
    Q1: Apr 22 4.95
    Q2: Jul 22 3.04
    Q3: Oct 22 -14.32
    Q4: Dec 22 -4.43
    Q1: Apr 23 -10.81
    Q2: Jul 23 -10.41
    Q3: Oct 23 6.78
    Q4: Dec 23 -9.75
    Q1: Mar 24 2.34
    Q2: Jun 24 4.31
    Q3: Sep 24 5.25
    Q4: Dec 24 5.26
    Q1: Mar 25 2.39
    Q2: Jun 25 5.77
    Q3: Sep 25 6.77
    Q4: Dec 25 9.08
    Q1: Mar 26 9.91

    2025

    Johnson & Johnson’s annual revenue increased +6.05% during fiscal year 2025 compared to 2024. It represents a growth of $5.37 B from $88.82 B (in 2024) to $94.19 B (in 2025).

    2024

    Johnson & Johnson’s annual revenue increased +4.30% during fiscal year 2024 compared to 2023. It represents a growth of $3.66 B from $85.16 B (in 2023) to $88.82 B (in 2024).

    2023

    Johnson & Johnson’s annual revenue increased +6.46% during fiscal year 2023 compared to 2022. It represents a growth of $5.17 B from $79.99 B (in 2022) to $85.16 B (in 2023).

    2022

    Johnson & Johnson’s annual revenue increased +1.59% during fiscal year 2022 compared to 2021. It represents a growth of $1.25 B from $78.74 B (in 2021) to $79.99 B (in 2022).

    2021

    Johnson & Johnson’s annual revenue decreased -4.65% during fiscal year 2021 compared to 2020. It represents a decline of $3.84 B from $82.58 B (in 2020) to $78.74 B (in 2021).

    2020

    Johnson & Johnson’s annual revenue increased +0.64% during fiscal year 2020 compared to 2019. It represents a growth of $525.00 M from $82.06 B (in 2019) to $82.58 B (in 2020).

    2019

    Johnson & Johnson’s annual revenue increased +0.59% during fiscal year 2019 compared to 2018. It represents a growth of $478.00 M from $81.58 B (in 2018) to $82.06 B (in 2019).

    2018

    Johnson & Johnson’s annual revenue increased +6.71% during fiscal year 2018 compared to 2017. It represents a growth of $5.13 B from $76.45 B (in 2017) to $81.58 B (in 2018).

    2017

    Johnson & Johnson’s annual revenue increased +6.34% during fiscal year 2017 compared to 2016. It represents a growth of $4.56 B from $71.89 B (in 2016) to $76.45 B (in 2017).

    2016

    Johnson & Johnson’s annual revenue increased +2.59% during fiscal year 2016 compared to 2015. It represents a growth of $1.82 B from $70.07 B (in 2015) to $71.89 B (in 2016).

    Continue reading...

    Johnson & Johnson Revenue History

    Sign in to download table

    Period Revenue Year-over-Year Change

    Get instant access to data, Sign up for free

    FY 2025
    $94.19 B $5.37 B 6.05%
    Q4: Dec 25 $24.56 B $2.04 B 9.08%
    Q3: Sep 25 $23.99 B $1.52 B 6.77%
    Q2: Jun 25 $23.74 B $1.30 B 5.77%
    Q1: Mar 25 $21.89 B $510.00 M 2.39%

    Get instant access to data, Sign up for free

    FY 2024
    $88.82 B $3.66 B 4.3%
    Q4: Dec 24 $22.52 B $1.13 B 5.26%
    Q3: Sep 24 $22.47 B $1.12 B 5.25%
    Q2: Jun 24 $22.45 B $928.00 M 4.31%
    Q1: Mar 24 $21.38 B $489.00 M 2.34%

    Get instant access to data, Sign up for free

    FY 2023
    $85.16 B $5.17 B 6.46%
    Q4: Dec 23 $21.40 B -$2.31 B 9.75%
    Q3: Oct 23 $21.35 B $1.36 B 6.78%
    Q2: Jul 23 $21.52 B -$2.50 B 10.41%
    Q1: Apr 23 $20.89 B -$2.53 B 10.81%

    Get instant access to data, Sign up for free

    FY 2022
    $79.99 B $1.25 B 1.59%
    Q4: Dec 22 $23.71 B -$1.10 B 4.43%
    Q3: Oct 22 $20.00 B -$3.34 B 14.32%
    Q2: Jul 22 $24.02 B $708.00 M 3.04%
    Q1: Apr 22 $23.43 B $1.11 B 4.95%

    Get instant access to data, Sign up for free

    FY 2021
    $78.74 B -$3.84 B 4.65%
    Q4: Dec 21 $24.80 B $2.33 B 10.36%
    Q3: Oct 21 $23.34 B $2.26 B 10.7%
    Q2: Jul 21 $23.31 B $4.98 B 27.14%
    Q1: Apr 21 $22.32 B $1.63 B 7.88%

    Get instant access to data, Sign up for free

    FY 2020
    $82.58 B $525.00 M 0.64%
    Q4: Dec 20 $22.48 B $1.73 B 8.33%
    Q3: Sep 20 $21.08 B $353.00 M 1.7%
    Q2: Jun 20 $18.34 B -$2.23 B 10.83%
    Q1: Mar 20 $20.69 B $670.00 M 3.35%

    Get instant access to data, Sign up for free

    FY 2019
    $82.06 B $478.00 M 0.59%
    Q4: Dec 19 $20.75 B $353.00 M 1.73%
    Q3: Sep 19 $20.73 B $381.00 M 1.87%
    Q2: Jun 19 $20.56 B -$268.00 M 1.29%
    Q1: Mar 19 $20.02 B $12.00 M 0.06%

    Get instant access to data, Sign up for free

    FY 2018
    $81.58 B $5.13 B 6.71%
    Q4: Dec 18 $20.39 B $199.00 M 0.99%
    Q3: Sep 18 $20.35 B $698.00 M 3.55%
    Q2: Jul 18 $20.83 B $1.99 B 10.57%
    Q1: Apr 18 $20.01 B $2.24 B 12.63%

    Get instant access to data, Sign up for free

    FY 2017
    $76.45 B $4.56 B 6.34%
    Q4: Dec 17 $20.20 B $2.09 B 11.54%
    Q3: Oct 17 $19.65 B $1.83 B 10.27%
    Q2: Jul 17 $18.84 B $357.00 M 1.93%
    Q1: Apr 17 $17.77 B $284.00 M 1.62%

    Get instant access to data, Sign up for free

    FY 2016
    $71.89 B $1.82 B 2.59%
    Q4: Dec 16 $18.11 B $295.00 M 1.66%
    Q3: Oct 16 $17.82 B $718.00 M 4.2%
    Q2: Jul 16 $18.48 B $695.00 M 3.91%
    Q1: Apr 16 $17.48 B $108.00 M 0.62%

    Frequently Asked Questions

    What is the annual revenue of Johnson & Johnson?

    In fiscal year 2025, Johnson & Johnson's revenue was $94.19 Billion.

    How much did Johnson & Johnson's revenue change in the last year?

    Johnson & Johnson's revenue increased by +6.05% (+$5.37 Billion) in 2025 compared to 2024.

    What is Johnson & Johnson's most recent quarterly revenue?

    In the first quarter (Q1) of 2026, Johnson & Johnson reported a revenue of $24.06 Billion.

    What is Johnson & Johnson's revenue per share (TTM)?

    Johnson & Johnson's revenue per share over the trailing twelve months is $39.41.

    What is Johnson & Johnson's revenue per employee?

    In the fiscal year 2025, Johnson & Johnson's revenue per employee was $681.57 K.

    What is the annual net income of Johnson & Johnson?

    In fiscal year 2025, Johnson & Johnson's net income was $26.80 Billion.

    What is Johnson & Johnson's biggest product segment, and what is its revenue?

    Innovative Medicine is Johnson & Johnson's biggest product segment, generating $60.40 Billion in revenue for fiscal year 2025.

    What is Johnson & Johnson's net income per employee?

    In the fiscal year 2025, Johnson & Johnson's net income per employee was $193.95 K.

    Related

    • A logo Agilent Technologies Revenue
    • LLY logo Eli Lilly and Company Revenue
    • SYK logo Stryker Corporation Revenue
    • ABBV logo AbbVie Revenue
    • MRK logo Merck & Co. Revenue
    • TMO logo Thermo Fisher Scientific Revenue
    • ABT logo Abbott Laboratories Revenue
    • DHR logo Danaher Corporation Revenue
    • AMGN logo Amgen Revenue

    People Also Search For

    • CAT logo Caterpillar
    • AAPL logo Apple
    • NVDA logo NVIDIA Corporation
    • MSFT logo Microsoft Corporation
    • AMZN logo Amazon.com
    • TSLA logo Tesla
    • GOOGL logo Alphabet (Google)
    • NKE logo NIKE
    • WMT logo Walmart
    • META logo Meta Platforms (Facebook)
    • PEP logo PepsiCo
    • TGT logo Target Corporation
    footer logo

    Bullfincher is a “visual-first” business intelligence and research platform. We believe that behind every great company, there is a great story. At Bullfincher, we make story-telling a little easier using dynamic visuals, charts, and graphs.

    explore
    • About Us
    • Blog
    • FAQ
    • Glossary
    Discover
    • Privacy Policy
    • Contact us
    • Submit Feedback
    • Advertise with Us
    Subscribe to our Newsletter !

    Don’t worry, we won’t spam you.

    Disclaimers - All data and information is provided “as is” for informational purposes only and is not intended for trading purposes or financial, investment, tax, legal, accounting, or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. Bullfincher is not an investment adviser, financial adviser, or a securities broker.None of the data and information constitutes investment advice nor an offering, recommendation, or solicitation by Bullfincher to buy, sell, or hold any security or financial product, and Bullfincher makes no representation (and has no opinion) regarding the advisability or suitability of any investment.

    None of the data and information constitutes investment advice (whether general or customized). The financial products or operations referred to in such data and information may not be suitable for your investment profile and investment objectives or expectations. It is your responsibility to consider whether any financial product or operation is suitable foryou based on your interests, investment objectives, investment horizon, and risk appetite. Bullfincher shall not be liable for any damages arising from any operations or investments in financial products referred to within. Bullfincher does not recommend using the data and information provided as the only basis for making any investment decision.

    Bullfincher 2026, All rights reserved

    Submit feedback to Bullfincher

    Submit your feedback


    Note: Please upload only jpg and png file and size 5 MB allowed.